GBLX CURE ETF UNITSGBLX CURE ETF UNITSGBLX CURE ETF UNITS

GBLX CURE ETF UNITS

Inga transaktioner
Se i superdiagram

Nyckeltal

Assets under management (AUM)
‪39.97 M‬AUD
Fund flows (1Y)
‪−6.34 M‬AUD
Dividend yield (indicated)
Discount/Premium to NAV
−0.03%

Om GBLX CURE ETF UNITS

Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Expense ratio
0.45%
Inception date
8 nov. 2018
Index tracked
S&P Biotechnology Select Industry
Management style
Passive
ISIN
AU0000028110

Classification

Asset Class
Equity
Kategori
Sektor
Focus
Sjukvård
Niche
Bioteknik
Strategi
Prisviktad
Weighting scheme
Pris
Selection criteria
Utskott

Returns

1 månad3 månaderHittills i år1 år3 år5 år
Price performance
NAV total return

What's in the fund

As of 17 maj 2024
Exposure type
AktierBonds, Cash & Other
Hälsoteknik
Aktier98.07%
Hälsoteknik97.23%
Hälsotjänster0.84%
Bonds, Cash & Other1.93%
ETF1.73%
Likvida medel0.20%
Stock breakdown by region
100%
Nordamerika100.00%
Latinamerika0.00%
Europa0.00%
Asien0.00%
Afrika0.00%
Mellanöstern0.00%
Oceanien0.00%
Top 10 holdings

Utdelningar

Utdelningshistorik

Assets under management (AUM)

Fund Flows